Cargando…
Shedding Light on the Possible Link between ADAMTS13 and Vaccine—Induced Thrombotic Thrombocytopenia
Several recent reports have highlighted the onset of vaccine-induced thrombotic thrombocytopaenia (VITT) in some recipients (approximately 1 case out of 100k exposures) of the ChAdOx1 nCoV-19 vaccine (AstraZeneca). Although the underlying events leading to this blood-clotting phenomenon has yet to b...
Autores principales: | Szóstek-Mioduchowska, Anna, Kordowitzki, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535032/ https://www.ncbi.nlm.nih.gov/pubmed/34685765 http://dx.doi.org/10.3390/cells10102785 |
Ejemplares similares
-
ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023) -
Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia
por: Sholzberg, Michelle, et al.
Publicado: (2021) -
Disappearing acts of ADAMTS13
por: Voorberg, Jan, et al.
Publicado: (2015) -
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
por: Sarig, Galit
Publicado: (2014) -
Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)